Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A reveal several negative factors: declining statutory capital and claims paying resources, increased losses, and regulatory challenges. Although there are improvements in some financial metrics, the overall sentiment is negative due to uncertainties surrounding PREPA, the lack of a shareholder return plan, and unclear management responses. The Q&A highlights concerns about strategic and financial uncertainties, further supporting a negative outlook. Without a market cap, we assume moderate impact, leading to a predicted stock price movement in the negative range (-2% to -8%).
Consolidated GAAP Net Loss (Q4 2024) $51 million (improved from $138 million in Q4 2023) - driven by reduced investment losses, lower operating expenses, and foreign exchange gains.
Consolidated GAAP Net Loss (Full Year 2024) $447 million (improved from $491 million in 2023) - due to lower net realized investment losses and lower operating expenses, partially offset by fair value losses on assets and higher loss in LAE.
Adjusted Net Loss (Q4 2024) $22 million (worsened from $8 million in Q4 2023) - primarily due to higher loss in LAE and lower net investment income.
Adjusted Net Loss (Full Year 2024) $184 million (worsened from $169 million in 2023) - primarily due to higher loss in LAE and lower net investment income.
Book Value per Share (End of 2024) Negative $40.99 (decreased from negative $32.56 at end of 2023) - primarily due to consolidated net loss for full year 2024.
Total Assets (Corporate Segment) $707 million (compared to $411 million at end of 2023) - decrease due to spending on purchasing liabilities.
Unencumbered Cash and Liquid Assets (Corporate Segment) $380 million (decreased from $411 million at end of 2023) - decrease due to spending on purchasing liabilities.
Statutory Net Loss (National Q4 2024) $10 million (worsened from $9 million in Q4 2023) - due to higher loss in LAE related to PREPA exposure.
Statutory Net Loss (National Full Year 2024) $133 million (improved from $142 million in 2023) - due to lower net realized investment losses.
Statutory Capital (National End of 2024) $912 million (down $205 million from end of 2023) - due to statutory net loss and dividend paid to MBIA Inc.
Claims Paying Resources (National End of 2024) $1.5 billion (down $174 million from end of 2023) - decrease attributed to statutory net loss.
Statutory Net Income (MBIA Insurance Corp. Q4 2024) $4 million (decreased from $6 million in Q4 2023) - due to higher loss in LAE.
Statutory Net Loss (MBIA Insurance Corp. Full Year 2024) $64 million (worsened from $28 million in 2023) - driven by higher loss in LAE.
Statutory Capital (MBIA Insurance Corp. End of 2024) $88 million (down from $152 million at end of 2023) - primarily due to net loss.
Claims Paying Resources (MBIA Insurance Corp. End of 2024) $356 million (down from $504 million at end of 2023) - decrease attributed to statutory net loss.
Insured Gross Par Outstanding (MBIA Insurance Corp. End of 2024) $2.3 billion (down about 18% from end of 2023) - driven by amortization and proactive derisking.
Claims Paying Resources: National had total claims paying resources of $1.5 billion and statutory capital and surplus in excess of $900 million.
Gross Par Amount Outstanding: The gross par amount outstanding for National’s insured portfolio has declined by approximately $3.1 billion from year-end 2023 to about $25 billion at the end of 2024.
Statutory Capital: National's statutory capital as of December 31, 2024, was $912 million, down $205 million compared to December 31, 2023.
Corporate Segment Assets: The Corporate segment had total assets of approximately $707 million as of December 31, 2024.
Unencumbered Cash and Liquid Assets: Unencumbered cash and liquid assets held by MBIA Inc. totaled $380 million compared with $411 million as of December 31, 2023.
PREPA Exposure Resolution: The priority continues to be resolving National’s PREPA exposure, with uncertainty regarding the outcomes for National’s PREPA bankruptcy claim, which is in excess of $800 million.
Dividend Payment: In the fourth quarter of 2024, National declared and paid an as-of-right dividend of $69 million to MBIA Inc.
PREPA Exposure: The uncertainty surrounding the resolution of National’s PREPA bankruptcy claim, which exceeds $800 million, poses a significant risk to the company. The path and timing for resolving PREPA’s outstanding debt remain largely uncertain, which could impact shareholder value.
Investment Losses: The company reported lower net realized investment losses in 2024 compared to 2023, but the potential for future investment losses remains a concern, particularly given the volatility in market conditions.
Claims Paying Resources: National’s claims paying resources decreased by $174 million from the previous year, which could affect the company’s ability to meet future claims.
Statutory Capital: National’s statutory capital decreased by $205 million compared to the previous year, raising concerns about the financial stability and operational capacity of the insurance segment.
Economic Factors: General market conditions and competitive pressures could lead to material differences in actual results compared to forward-looking statements, indicating potential economic risks.
Regulatory Issues: The competitive environment and regulatory challenges could impact the company’s operations and financial performance, as highlighted in the safe harbor disclosure.
PREPA Exposure Resolution: The priority continues to be resolving National’s PREPA exposure, with an outstanding debt claim in excess of $800 million. The process to sell the company to maximize shareholder value will likely require reducing uncertainty regarding PREPA.
Insured Portfolio Performance: The balance of National’s insured portfolio has performed generally consistent with expectations, with a gross par amount outstanding declining by approximately $3.1 billion from year-end 2023 to about $25 billion at the end of 2024.
Corporate Segment Assets: The Corporate segment had total assets of approximately $707 million as of December 31, 2024, including $380 million in unencumbered cash and liquid assets.
Future Revenue Expectations: The company reported a consolidated GAAP net loss of $447 million for full year 2024, an improvement from a net loss of $491 million in 2023.
Claims Paying Resources: National had total claims paying resources of $1.5 billion as of December 31, 2024, down from $1.674 billion at year-end 2023.
Statutory Capital: National’s statutory capital was $912 million as of December 31, 2024, down $205 million compared to December 31, 2023.
As-of-right dividend paid: National declared and paid an as-of-right dividend of $69 million to MBIA Inc. in December of 2024.
Shareholder Return Plan: None
The earnings call summary shows mixed results: strong improvement in National's performance due to reduced losses and LAE, but MBIA Insurance Corp. faces losses and declining resources. The Q&A reveals uncertainties about strategic decisions and potential delays in oversight board approvals. While the company has buyback capacity and improved net income, the unresolved PREPA exposure and unclear strategic direction temper enthusiasm. The market may remain cautious, leading to a neutral stock price movement.
The earnings call summary and Q&A indicate several uncertainties and potential negative trends, particularly around PREPA exposure and restructuring impacts. While there are some positive financial metrics, such as increased statutory capital and reduced losses, the market uncertainty around PREPA, lack of clarity on restructuring impacts, and potential sale uncertainty weigh negatively. The Q&A highlighted unclear responses from management and unresolved issues, which likely contribute to a negative market sentiment and stock price reaction.
The earnings call reveals a mix of improved financial metrics but significant ongoing risks. The uncertainty surrounding the $800 million PREPA claim and high leverage ratio pose considerable risks. The lack of shareholder return announcements and negative book value per share further dampen sentiment. Although there are improvements in net losses and statutory capital, the absence of clear guidance and strategic clarity in the Q&A section adds to the negative outlook. Without a market cap, the overall sentiment leans negative, suggesting a potential stock price decline of -2% to -8%.
The earnings call summary and Q&A reveal several negative factors: declining statutory capital and claims paying resources, increased losses, and regulatory challenges. Although there are improvements in some financial metrics, the overall sentiment is negative due to uncertainties surrounding PREPA, the lack of a shareholder return plan, and unclear management responses. The Q&A highlights concerns about strategic and financial uncertainties, further supporting a negative outlook. Without a market cap, we assume moderate impact, leading to a predicted stock price movement in the negative range (-2% to -8%).
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.